A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity

Adjei, A A ; Erlichman, C ; Davis, J N ; Cutler, D L ; Sloan, J A ; Marks, R S ; Hanson, L J ; Svingen, P A ; Atherton, P ; Bishop, W R ; Kirschmeier, P ; Kaufmann, S H

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (7), p.1871 [Periódico revisado por pares]

United States

Texto completo disponível